Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

類似資料

• Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)
  著者:: Sinicrope, Frank A., 等
  出版事項: (2015)
• Association of DNA Mismatch Repair and Mutations in BRAF and KRAS with Survival after Recurrence in Stage III Colon Cancers from Phase III Adjuvant Chemotherapy Trials
  著者:: Sinicrope, Frank A., 等
  出版事項: (2017)
• Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials
  著者:: Zaanan, Aziz, 等
  出版事項: (2017)
• DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer
  著者:: Sinicrope, Frank A.
  出版事項: (2010)
• Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
  著者:: Hu, Huabin, 等
  出版事項: (2020)